Related Experiment Video
Updated: Jul 19, 2026

Non-restraining EEG Radiotelemetry: Epidural and Deep Intracerebral Stereotaxic EEG Electrode Placement
Published on: June 25, 2016
Seizures during intracarotid methohexital and amobarbital testing
Tobias Loddenkemper1, Gabriel Möddel, Stephan U Schuele
1Department of Neurology, Cleveland Clinic, Cleveland, OH, USA. loddent@ccf.org
Background:
Methohexital and amobarbital have been used as agents for Wada testing in the presurgical evaluation of patients with epilepsy. Previous experience with methohexital as an anesthetic indicates that methohexital may decrease seizure threshold and may trigger seizures.
Methods:
A retrospective chart review of 760 intracarotid amobarbital and methohexital tests was performed to determine the frequency of seizures associated with preoperative intracarotid barbiturate testing for language and memory lateralization.
Results:
Sixteen patients (2.1%) who had seizures were found. In 3 patients, seizures occurred prior to barbiturate injection, and in 13, following barbiturate injection. After injection of amobarbital, 4 of 538 patients (0.7%) had a seizure. Nine of 222 patients had a seizure after methohexital injection (4.1%) (P=0.001).
Conclusion:
Patients with a previous history of epilepsy may be at higher risk for seizures after methohexital injection as compared with amobarbital injection.
Related Concept Videos
Seizures l: Introduction
Antiepileptic Drugs: Potassium Channel Activators
Ezogabine has gained approval as an adjunctive treatment...
Seizures ll: Types

